Xylem Sees Unusually High Options Volume (NYSE:XYL)

Xylem Inc. (NYSE:XYL) saw unusually large options trading on Thursday. Stock traders bought 20,508 call options on the company. This represents an increase of 771% compared to the average volume of 2,355 call options.

Xylem Stock Performance

NYSE:XYL opened at $90.74 on Friday. The business’s fifty day moving average is $105.47 and its 200 day moving average is $117.80. The firm has a market cap of $20.81 billion, a price-to-earnings ratio of 20.08, a PEG ratio of 1.47 and a beta of 1.00. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.24 and a current ratio of 1.39. Xylem has a 52-week low of $87.40 and a 52-week high of $154.27.

Xylem (NYSE:XYL) last announced its quarterly earnings results on Tuesday, October 27th. The industrial products company reported $1.44 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.45 by ($0.01). Xylem had a return on equity of 12.06% and a net margin of 11.94%. The firm had revenue of $2.20 billion during the quarter, compared to analysts’ expectations of $2.28 billion. During the same period in the previous year, the company posted $1.37 earnings per share. The company’s quarterly revenue was down 3.0% compared to the same quarter last year. Research analysts predict that Xylem will post 5.47 EPS for the current year.

Xylem Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, September 24th. Investors of record on Thursday, August 27th were given a $0.43 dividend. This represents a $1.72 annualized dividend and a dividend yield of 1.9%. The ex-dividend date was Thursday, August 27th. Xylem’s dividend payout ratio is 40.95%.

Insider Buying and Selling at Xylem

In related news, Director D Koch purchased 11,000 shares of the business’s stock in a transaction that occurred on Thursday, October 29th. The shares were bought at an average cost of $89.60 per share, with a total value of $985,600.00. Following the acquisition, the director owned 12,247 shares of the company’s stock, valued at $1,097,331.20. This represents a 882.12% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. Company insiders own 0.32% of the company’s stock.

Hedge Funds Weigh In On Xylem

A number of hedge funds and other institutional investors have recently bought and sold shares of XYL. Mountain Pacific Investment Advisers LLC lifted its holdings in Xylem by 5.5% in the 3rd quarter. Mountain Pacific Investment Advisers LLC now owns 141,766 shares of the industrial products company’s stock worth $14,357,000 after buying an additional 7,403 shares during the period. GRIMES & Co WEALTH MANAGEMENT LLC increased its stake in shares of Xylem by 2.2% during the third quarter. GRIMES & Co WEALTH MANAGEMENT LLC now owns 57,742 shares of the industrial products company’s stock valued at $5,848,000 after buying an additional 1,235 shares during the period. Next Level Wealth Planning LLC purchased a new position in shares of Xylem during the third quarter valued at approximately $71,000. Woodmont Investment Counsel LLC increased its stake in shares of Xylem by 5.7% during the third quarter. Woodmont Investment Counsel LLC now owns 49,043 shares of the industrial products company’s stock valued at $4,967,000 after buying an additional 2,655 shares during the period. Finally, Bank Julius Baer & Co. Ltd Zurich raised its holdings in shares of Xylem by 9.5% during the third quarter. Bank Julius Baer & Co. Ltd Zurich now owns 116,885 shares of the industrial products company’s stock valued at $11,834,000 after acquiring an additional 10,149 shares in the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Key Headlines Impacting Xylem

Here are the key news stories impacting Xylem this week:

• Positive Sentiment: Director D. Christian Koch purchased 11,000 shares for approximately $985,600, increasing his direct ownership more than eightfold. The sizable insider purchase may signal confidence that the selloff has created attractive value. Insider purchase article
• Positive Sentiment: RBC maintained a positive view and initiated coverage with a “moderate buy” rating and a $125 price target, implying substantial potential upside from recent trading levels. RBC rating article
• Positive Sentiment: Call-option activity surged to 20,508 contracts, roughly 771% above typical volume, indicating that some traders are positioning for a recovery.
• Neutral Sentiment: Xylem announced divestitures and a new three-segment structure. The changes could sharpen strategic focus and improve portfolio efficiency, although execution and transition risks remain. Restructuring article
• Neutral Sentiment: Analyst opinion is divided: several firms retained buy or outperform ratings, but most reduced their price targets. The average published target remains well above the current share price, suggesting longer-term upside if growth recovers.
• Negative Sentiment: Third-quarter revenue of $2.20 billion missed the $2.28 billion consensus estimate, while EPS of $1.44 narrowly missed expectations. Revenue declined 3% year over year, reinforcing concerns about near-term demand and growth.
• Negative Sentiment: Barclays downgraded Xylem to equal weight, JPMorgan moved to underweight with a $90 target, and UBS cut its target to $99 with a neutral rating. Stifel, BNP Paribas Exane, Citigroup and Oppenheimer also lowered targets, weighing on sentiment. Barclays downgrade article

Analyst Ratings Changes

A number of research analysts have recently weighed in on XYL shares. Citigroup reduced their target price on shares of Xylem from $148.00 to $130.00 and set a “buy” rating for the company in a research report on Wednesday. Wolfe Research assumed coverage on Xylem in a research note on Tuesday, September 15th. They issued a “peer perform” rating on the stock. Barclays lowered Xylem from an “overweight” rating to an “equal weight” rating and reduced their price objective for the company from $139.00 to $104.00 in a report on Wednesday. UBS Group decreased their target price on Xylem from $112.00 to $99.00 and set a “neutral” rating for the company in a research report on Thursday. Finally, Royal Bank Of Canada lowered their target price on Xylem from $135.00 to $125.00 and set an “outperform” rating on the stock in a research note on Wednesday. Nine equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $121.31.

Xylem Company Profile

Xylem Inc (NYSE: XYL) is a global water technology company that develops products and services for the transportation, treatment, testing and efficient use of water and wastewater. Its offerings support municipal water and wastewater utilities, industrial customers, commercial facilities and residential applications.

The company’s products and solutions include water and wastewater pumps, treatment systems, dewatering equipment, smart meters, monitoring and control technologies, leak detection tools, and data-driven analytics.